IDEXX Laboratories Business Summary

IDEXX Laboratories, Inc. (IDXX) operates a high-margin "razor-and-blades" business model, deriving the vast majority of its revenue from recurring streams including diagnostic consumables, reference laboratory services, and cloud-based practice management software. The company is organized into three primary segments: the Companion Animal Group (CAG), which accounts for approximately 92% of total revenue through veterinary diagnostic instruments and services; Water Quality Products, focusing on microbiology testing; and Livestock, Poultry, and Dairy (LPD), providing health monitoring for production animals. IDEXX maintains a dominant market position with an estimated 60-65% share of the North American in-clinic diagnostics segment, leveraging its integrated ecosystem to create high switching costs. Its primary competitors include Zoetis Inc., Mars Petcare (via its Antech and Heska subsidiaries), and Thermo Fisher Scientific, though IDEXX distinguishes itself through superior software integration and a massive global installed base of premium analyzers like the Catalyst and ProCyte lines. Founded in 1983 by David Evans Shaw, IDEXX is currently led by President and CEO Jonathan (Jay) Mazelsky, a former Philips Healthcare executive who has overseen a period of significant stock outperformance and innovation since 2019. In January 2026, the company announced a formal succession plan where Michael (Mike) Erickson, PhD—currently Executive VP and a former McKinsey & Company consultant—will assume the CEO role on May 12, 2026, with Mazelsky transitioning to Executive Chair. The leadership team is bolstered by Executive VP and CFO Andrew Emerson and CTO Martin Smith, who spearheads the firm’s AI-driven diagnostic initiatives such as the inVue Dx cellular analyzer. The Board of Directors is chaired by Lawrence D. Kingsley and features high-pedigree members including Sam Samad (CFO of Quest Diagnostics) and Stuart M. Essig (Chair of Integra LifeSciences), reflecting a governance structure deeply rooted in global healthcare and financial services expertise.